These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7955070)

  • 1. Detection of O6-butyl- and O6-(4-hydroxybutyl)guanine in urothelial and hepatic DNA of rats given the bladder carcinogen N-nitrosobutyl(4-hydroxybutyl)amine.
    Airoldi L; Magagnotti C; Bonfanti M; Chiappetta L; Lolli M; Medana C; De Gregorio G; Fanelli R
    Carcinogenesis; 1994 Oct; 15(10):2297-301. PubMed ID: 7955070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of O6-butylguanine in DNA by immunoaffinity extraction/gas chromatography-mass spectrometry.
    Bonfanti M; Magagnotti C; Galli A; Bagnati R; Moret M; Gariboldi P; Fanelli R; Airoldi L
    Cancer Res; 1990 Nov; 50(21):6870-5. PubMed ID: 2208155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro metabolism of bladder carcinogenic nitrosamines by rat liver and urothelial cells.
    Airoldi L; Magagnotti C; De Gregorio G; Moret M; Fanelli R
    Chem Biol Interact; 1992 Apr; 82(2):231-40. PubMed ID: 1568272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an experimental model for studying bladder carcinogen metabolism using the isolated rat urinary bladder.
    Airoldi L; Bonfanti M; Magagnotti C; Fanelli R
    Cancer Res; 1987 Jul; 47(14):3697-700. PubMed ID: 3594434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation adduct formation and H-ras gene mutations in progression of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tumors caused by a single exposure to N-methyl-N-nitrosourea.
    Shibata MA; Shirai T; Ogawa K; Takahashi S; Wild CP; Montesano R; Tsuda H; Ito N
    Carcinogenesis; 1994 Dec; 15(12):2965-8. PubMed ID: 8001265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-oxidative metabolism of the bladder carcinogens N-nitrosobutyl(4-hydroxybutyl)amine and N-nitrosobutyl(3-carboxypropyl)amine within the rat isolated bladder.
    Airoldi L; Magagnotti C; Bonfanti M; Fanelli R
    Carcinogenesis; 1990 Aug; 11(8):1437-40. PubMed ID: 2387032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
    PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of N-butyl-N-(hydroxybutyl)-nitrosamine-induced tumors in the partially resected, proliferating rat urinary bladder in dependence upon the time of onset of stimulated DNA synthesis.
    Kunze E; Könnecke B; Nienaber C
    Urol Res; 1990; 18(5):319-22. PubMed ID: 2256232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.
    Lubet RA; Fischer SM; Steele VE; Juliana MM; Desmond R; Grubbs CJ
    Int J Cancer; 2008 Nov; 123(10):2254-9. PubMed ID: 18712722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine as the basis for urothelial carcinogenesis.
    He Z; Kosinska W; Zhao ZL; Wu XR; Guttenplan JB
    Mutat Res; 2012 Feb; 742(1-2):92-5. PubMed ID: 22155125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Damage and repair of DNA in urinary bladder epithelium of rats treated with N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Tsuda H; Miyata Y; Hagiwara A; Hasegawa R; Shirai T; Ito N
    Gan; 1977 Dec; 68(6):781-3. PubMed ID: 598647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Nitrosobutyl(4-hydroxybutyl)amine alpha-hydroxylation by rat liver and urothelial cell homogenates.
    Airoldi L; Magagnotti C; Bonfanti M; Moret M; Fanelli R
    IARC Sci Publ; 1991; (105):343-5. PubMed ID: 1855877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lupeol on antioxidants and xenobiotic enzymes in N-Butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
    Prabhu B; Sivakumar A; Balakrishnan D; Sundaresan S
    J Exp Ther Oncol; 2017 Sep; 11(2):139-416. PubMed ID: 28976137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay.
    Wakui S; Mutou T; Takahashi H; Ikegami M; Wanibuchi H; Fukushima S
    J Appl Toxicol; 2015 Feb; 35(2):181-90. PubMed ID: 24888239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel, sensitive assay for O6-methyl- and O6-ethylguanine in DNA, based on repair by the enzyme O6-alkylguanine-DNA-alkyltransferase in competition with an oligonucleotide containing O6-methylguanine.
    Souliotis VL; Kyrtopoulos SA
    Cancer Res; 1989 Dec; 49(24 Pt 1):6997-7001. PubMed ID: 2684406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor development in the regenerating rat urinary bladder stimulated to proliferate by cyclophosphamide.
    Kunze E; Töpfer S; Zöller N
    Eur J Cancer Clin Oncol; 1984 May; 20(5):711-7. PubMed ID: 6539704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl isothiocyanate and N-butyl-N-(4-hydroxybutyl)nitrosamine in rats after initiation.
    Okazaki K; Umemura T; Imazawa T; Nishikawa A; Masegi T; Hirose M
    Cancer Sci; 2003 Nov; 94(11):948-52. PubMed ID: 14611670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on "tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl) nitrosamine as the basis for urothelial cell carcinogenesis." He Z, Kosinska W, Zhao ZL, Wu XR, Guttenplan JB, Department of Basic Science, New York University Dental College, NY, USA.: Mutat Res 2012;742(1-2):92-5 [Epub 2011 Dec 4].
    Scherr DS
    Urol Oncol; 2014 Feb; 32(2):214. PubMed ID: 24445298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okazaki K; Yamagishi M; Son HY; Imazawa T; Furukawa F; Nakamura H; Nishikawa A; Masegi T; Hirose M
    Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.
    Iida K; Itoh K; Kumagai Y; Oyasu R; Hattori K; Kawai K; Shimazui T; Akaza H; Yamamoto M
    Cancer Res; 2004 Sep; 64(18):6424-31. PubMed ID: 15374950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.